Haemophilus influenzae Type b Anticapsular Antibody Responses to PRP-Pertussis and PRP-D Vaccines in Alaska Native Infants

To evaluate immune responses in Alaska Native infants at high risk for invasive Haemophilus influenzae type b (Hib) disease, we studied PRP-pertussis and PRP-D conjugate vaccines in this population relative to responses in white infants in California and New York. Infants were immunized at two, four...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of infectious diseases 1988-10, Vol.158 (4), p.719-723
Hauptverfasser: Ward, Joel I., Brenneman, George, Lepow, Martha, Lum, Milton, Burkhart, Kelly, Chiu, Chung Y.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 723
container_issue 4
container_start_page 719
container_title The Journal of infectious diseases
container_volume 158
creator Ward, Joel I.
Brenneman, George
Lepow, Martha
Lum, Milton
Burkhart, Kelly
Chiu, Chung Y.
description To evaluate immune responses in Alaska Native infants at high risk for invasive Haemophilus influenzae type b (Hib) disease, we studied PRP-pertussis and PRP-D conjugate vaccines in this population relative to responses in white infants in California and New York. Infants were immunized at two, four, and six months of age (both vaccines). In the PRP-pertussis trial, there were no significant differences in antibody levels at any age between Alaska Native infants and infants from California. Only 50% of the infants had a two fold or greater antibody rise after three doses. In the PRP-D trial, antibody levels at two months of age (presumably maternally acquired) were significantly higher for Alaska Native infants compared with infants from New York (P = .002). There were no significant differences in antibody levels after any of the three doses. Among Alaska Native infants there was no significant difference in antibody response based upon degree of ethnic purity.
doi_str_mv 10.1093/infdis/158.4.719
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_78450870</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>30136374</jstor_id><sourcerecordid>30136374</sourcerecordid><originalsourceid>FETCH-LOGICAL-c329t-5cb3a7ce997d126f9cdd04b7bce381e0acbcf19e5f51b511f83cc9a9616a22ca3</originalsourceid><addsrcrecordid>eNqFkc9v0zAYhi0EGmVw54LkA-KWzo5jOz5240cnVdBNA6FdrC-OI7ylTuYvQXR_PelatiMn6_Pzvs_lJeQtZ3POjDgJsakDnnBZzou55uYZmXEpdKYUF8_JjLE8z3hpzEvyCvGGMVYIpY_IkchVrkwxI_dL8Juu_xXaEelka0cf78HTq23vaUUXcQgOehxbSA9H1dVbeumx7yJ6pENH15frbO3TMCIGpBDrh5-P9Ac4F6LfWemiBbwF-hWG8NvT89hAHPA1edFAi_7N4T0m3z9_ujpbZqtvX87PFqvMidwMmXSVAO28MbrmuWqMq2tWVLpyXpTcM3CVa7jxspG8kpw3pXDOgFFcQZ47EMfkw97bp-5u9DjYTUDn2xai70a0uiwkKzX7b5BLVjApxRRk-6BLHWLyje1T2EDaWs7sbhe732VqlLaw0y5T5d3BPVYbXz8WDkNM_P2BAzpomwTRTYJ_MWVMUSr2pLnBoUtPFsaFEnqnyfY84OD_PHJIt1ZpoaVd_ry2F6d8dcGvT-2p-AuOtrFj</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15040553</pqid></control><display><type>article</type><title>Haemophilus influenzae Type b Anticapsular Antibody Responses to PRP-Pertussis and PRP-D Vaccines in Alaska Native Infants</title><source>MEDLINE</source><source>JSTOR Archive Collection A-Z Listing</source><creator>Ward, Joel I. ; Brenneman, George ; Lepow, Martha ; Lum, Milton ; Burkhart, Kelly ; Chiu, Chung Y.</creator><creatorcontrib>Ward, Joel I. ; Brenneman, George ; Lepow, Martha ; Lum, Milton ; Burkhart, Kelly ; Chiu, Chung Y.</creatorcontrib><description>To evaluate immune responses in Alaska Native infants at high risk for invasive Haemophilus influenzae type b (Hib) disease, we studied PRP-pertussis and PRP-D conjugate vaccines in this population relative to responses in white infants in California and New York. Infants were immunized at two, four, and six months of age (both vaccines). In the PRP-pertussis trial, there were no significant differences in antibody levels at any age between Alaska Native infants and infants from California. Only 50% of the infants had a two fold or greater antibody rise after three doses. In the PRP-D trial, antibody levels at two months of age (presumably maternally acquired) were significantly higher for Alaska Native infants compared with infants from New York (P = .002). There were no significant differences in antibody levels after any of the three doses. Among Alaska Native infants there was no significant difference in antibody response based upon degree of ethnic purity.</description><identifier>ISSN: 0022-1899</identifier><identifier>EISSN: 1537-6613</identifier><identifier>DOI: 10.1093/infdis/158.4.719</identifier><identifier>PMID: 3262694</identifier><identifier>CODEN: JIDIAQ</identifier><language>eng</language><publisher>Chicago, IL: The University of Chicago Press</publisher><subject>Alaska ; Alaska Natives ; Antibodies ; Antibodies, Bacterial - biosynthesis ; Asian Continental Ancestry Group ; Bacterial Vaccines - immunology ; Biological and medical sciences ; California ; Conjugate vaccines ; Diphtheria Toxoid - immunology ; Disease risk ; Dosage ; Haemophilus influenzae ; Haemophilus influenzae - immunology ; Haemophilus influenzae type b ; Haemophilus Vaccines ; Humans ; Immune response ; Immunization, Secondary ; Immunopathology ; Immunotherapy (general aspects) ; Infant ; Major Articles ; Medical genetics ; Medical sciences ; New York ; Pertussis Vaccine - immunology ; Polysaccharides ; Vaccination</subject><ispartof>The Journal of infectious diseases, 1988-10, Vol.158 (4), p.719-723</ispartof><rights>Copyright 1988 The University of Chicago</rights><rights>1989 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c329t-5cb3a7ce997d126f9cdd04b7bce381e0acbcf19e5f51b511f83cc9a9616a22ca3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/30136374$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/30136374$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,803,27923,27924,58016,58249</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=6994860$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3262694$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ward, Joel I.</creatorcontrib><creatorcontrib>Brenneman, George</creatorcontrib><creatorcontrib>Lepow, Martha</creatorcontrib><creatorcontrib>Lum, Milton</creatorcontrib><creatorcontrib>Burkhart, Kelly</creatorcontrib><creatorcontrib>Chiu, Chung Y.</creatorcontrib><title>Haemophilus influenzae Type b Anticapsular Antibody Responses to PRP-Pertussis and PRP-D Vaccines in Alaska Native Infants</title><title>The Journal of infectious diseases</title><addtitle>J Infect Dis</addtitle><description>To evaluate immune responses in Alaska Native infants at high risk for invasive Haemophilus influenzae type b (Hib) disease, we studied PRP-pertussis and PRP-D conjugate vaccines in this population relative to responses in white infants in California and New York. Infants were immunized at two, four, and six months of age (both vaccines). In the PRP-pertussis trial, there were no significant differences in antibody levels at any age between Alaska Native infants and infants from California. Only 50% of the infants had a two fold or greater antibody rise after three doses. In the PRP-D trial, antibody levels at two months of age (presumably maternally acquired) were significantly higher for Alaska Native infants compared with infants from New York (P = .002). There were no significant differences in antibody levels after any of the three doses. Among Alaska Native infants there was no significant difference in antibody response based upon degree of ethnic purity.</description><subject>Alaska</subject><subject>Alaska Natives</subject><subject>Antibodies</subject><subject>Antibodies, Bacterial - biosynthesis</subject><subject>Asian Continental Ancestry Group</subject><subject>Bacterial Vaccines - immunology</subject><subject>Biological and medical sciences</subject><subject>California</subject><subject>Conjugate vaccines</subject><subject>Diphtheria Toxoid - immunology</subject><subject>Disease risk</subject><subject>Dosage</subject><subject>Haemophilus influenzae</subject><subject>Haemophilus influenzae - immunology</subject><subject>Haemophilus influenzae type b</subject><subject>Haemophilus Vaccines</subject><subject>Humans</subject><subject>Immune response</subject><subject>Immunization, Secondary</subject><subject>Immunopathology</subject><subject>Immunotherapy (general aspects)</subject><subject>Infant</subject><subject>Major Articles</subject><subject>Medical genetics</subject><subject>Medical sciences</subject><subject>New York</subject><subject>Pertussis Vaccine - immunology</subject><subject>Polysaccharides</subject><subject>Vaccination</subject><issn>0022-1899</issn><issn>1537-6613</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1988</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc9v0zAYhi0EGmVw54LkA-KWzo5jOz5240cnVdBNA6FdrC-OI7ylTuYvQXR_PelatiMn6_Pzvs_lJeQtZ3POjDgJsakDnnBZzou55uYZmXEpdKYUF8_JjLE8z3hpzEvyCvGGMVYIpY_IkchVrkwxI_dL8Juu_xXaEelka0cf78HTq23vaUUXcQgOehxbSA9H1dVbeumx7yJ6pENH15frbO3TMCIGpBDrh5-P9Ac4F6LfWemiBbwF-hWG8NvT89hAHPA1edFAi_7N4T0m3z9_ujpbZqtvX87PFqvMidwMmXSVAO28MbrmuWqMq2tWVLpyXpTcM3CVa7jxspG8kpw3pXDOgFFcQZ47EMfkw97bp-5u9DjYTUDn2xai70a0uiwkKzX7b5BLVjApxRRk-6BLHWLyje1T2EDaWs7sbhe732VqlLaw0y5T5d3BPVYbXz8WDkNM_P2BAzpomwTRTYJ_MWVMUSr2pLnBoUtPFsaFEnqnyfY84OD_PHJIt1ZpoaVd_ry2F6d8dcGvT-2p-AuOtrFj</recordid><startdate>198810</startdate><enddate>198810</enddate><creator>Ward, Joel I.</creator><creator>Brenneman, George</creator><creator>Lepow, Martha</creator><creator>Lum, Milton</creator><creator>Burkhart, Kelly</creator><creator>Chiu, Chung Y.</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T5</scope><scope>C1K</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>198810</creationdate><title>Haemophilus influenzae Type b Anticapsular Antibody Responses to PRP-Pertussis and PRP-D Vaccines in Alaska Native Infants</title><author>Ward, Joel I. ; Brenneman, George ; Lepow, Martha ; Lum, Milton ; Burkhart, Kelly ; Chiu, Chung Y.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c329t-5cb3a7ce997d126f9cdd04b7bce381e0acbcf19e5f51b511f83cc9a9616a22ca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1988</creationdate><topic>Alaska</topic><topic>Alaska Natives</topic><topic>Antibodies</topic><topic>Antibodies, Bacterial - biosynthesis</topic><topic>Asian Continental Ancestry Group</topic><topic>Bacterial Vaccines - immunology</topic><topic>Biological and medical sciences</topic><topic>California</topic><topic>Conjugate vaccines</topic><topic>Diphtheria Toxoid - immunology</topic><topic>Disease risk</topic><topic>Dosage</topic><topic>Haemophilus influenzae</topic><topic>Haemophilus influenzae - immunology</topic><topic>Haemophilus influenzae type b</topic><topic>Haemophilus Vaccines</topic><topic>Humans</topic><topic>Immune response</topic><topic>Immunization, Secondary</topic><topic>Immunopathology</topic><topic>Immunotherapy (general aspects)</topic><topic>Infant</topic><topic>Major Articles</topic><topic>Medical genetics</topic><topic>Medical sciences</topic><topic>New York</topic><topic>Pertussis Vaccine - immunology</topic><topic>Polysaccharides</topic><topic>Vaccination</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ward, Joel I.</creatorcontrib><creatorcontrib>Brenneman, George</creatorcontrib><creatorcontrib>Lepow, Martha</creatorcontrib><creatorcontrib>Lum, Milton</creatorcontrib><creatorcontrib>Burkhart, Kelly</creatorcontrib><creatorcontrib>Chiu, Chung Y.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ward, Joel I.</au><au>Brenneman, George</au><au>Lepow, Martha</au><au>Lum, Milton</au><au>Burkhart, Kelly</au><au>Chiu, Chung Y.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Haemophilus influenzae Type b Anticapsular Antibody Responses to PRP-Pertussis and PRP-D Vaccines in Alaska Native Infants</atitle><jtitle>The Journal of infectious diseases</jtitle><addtitle>J Infect Dis</addtitle><date>1988-10</date><risdate>1988</risdate><volume>158</volume><issue>4</issue><spage>719</spage><epage>723</epage><pages>719-723</pages><issn>0022-1899</issn><eissn>1537-6613</eissn><coden>JIDIAQ</coden><abstract>To evaluate immune responses in Alaska Native infants at high risk for invasive Haemophilus influenzae type b (Hib) disease, we studied PRP-pertussis and PRP-D conjugate vaccines in this population relative to responses in white infants in California and New York. Infants were immunized at two, four, and six months of age (both vaccines). In the PRP-pertussis trial, there were no significant differences in antibody levels at any age between Alaska Native infants and infants from California. Only 50% of the infants had a two fold or greater antibody rise after three doses. In the PRP-D trial, antibody levels at two months of age (presumably maternally acquired) were significantly higher for Alaska Native infants compared with infants from New York (P = .002). There were no significant differences in antibody levels after any of the three doses. Among Alaska Native infants there was no significant difference in antibody response based upon degree of ethnic purity.</abstract><cop>Chicago, IL</cop><pub>The University of Chicago Press</pub><pmid>3262694</pmid><doi>10.1093/infdis/158.4.719</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-1899
ispartof The Journal of infectious diseases, 1988-10, Vol.158 (4), p.719-723
issn 0022-1899
1537-6613
language eng
recordid cdi_proquest_miscellaneous_78450870
source MEDLINE; JSTOR Archive Collection A-Z Listing
subjects Alaska
Alaska Natives
Antibodies
Antibodies, Bacterial - biosynthesis
Asian Continental Ancestry Group
Bacterial Vaccines - immunology
Biological and medical sciences
California
Conjugate vaccines
Diphtheria Toxoid - immunology
Disease risk
Dosage
Haemophilus influenzae
Haemophilus influenzae - immunology
Haemophilus influenzae type b
Haemophilus Vaccines
Humans
Immune response
Immunization, Secondary
Immunopathology
Immunotherapy (general aspects)
Infant
Major Articles
Medical genetics
Medical sciences
New York
Pertussis Vaccine - immunology
Polysaccharides
Vaccination
title Haemophilus influenzae Type b Anticapsular Antibody Responses to PRP-Pertussis and PRP-D Vaccines in Alaska Native Infants
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T11%3A33%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Haemophilus%20influenzae%20Type%20b%20Anticapsular%20Antibody%20Responses%20to%20PRP-Pertussis%20and%20PRP-D%20Vaccines%20in%20Alaska%20Native%20Infants&rft.jtitle=The%20Journal%20of%20infectious%20diseases&rft.au=Ward,%20Joel%20I.&rft.date=1988-10&rft.volume=158&rft.issue=4&rft.spage=719&rft.epage=723&rft.pages=719-723&rft.issn=0022-1899&rft.eissn=1537-6613&rft.coden=JIDIAQ&rft_id=info:doi/10.1093/infdis/158.4.719&rft_dat=%3Cjstor_proqu%3E30136374%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15040553&rft_id=info:pmid/3262694&rft_jstor_id=30136374&rfr_iscdi=true